Evgen Pharma PLC Presentation at World Orphan Drug Congress USA

Evgen Pharma PLC (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced that Steve Franklin, the Company’s CEO, will present at the World Orphan Drug Congress USA 2018 in Maryland, Washington DC, on 26 April 2018.

The presentation, which is part of the Pitch & Partner track of the congress, will focus on SFX-01, the Company’s lead product, in the treatment of subarachnoid haemorrhage (“SAH”).  SFX-01 is currently in a Phase II clinical trial in SAH, which remains on track to report around the end of 2018.

The presentation will also refer to the ongoing Phase II trial of SFX-01 in metastatic breast cancer, which is on track to report an interim read-out in Q2 this year with the final read-out around the year end.

The World Orphan Drug Congress USA 2018, which will take place on 25-27 April 2018, focuses on all aspects of orphan drug development and rare disease research.

This will be the second international forum that Steve Franklin has been invited to address this month, having just returned from a closed meeting in Madrid where he presented the “SFX-01 for Subarachnoid Haemorrhage” clinical programme to senior scientists from pharmaceutical companies and academia, all with a common interest in the Nrf-2 pathway.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Evgen Pharma Plc

    More articles like this

    Evgen Pharma Plc

    Your Diet and Breast Cancer

    One in eight women will be diagnosed with breast cancer in their lifetime—of that number, studies show 85 percent of women don’t have a family history. “We know that physical activity makes a difference and we

    Evgen Pharma Plc

    Processed meat ‘linked to breast cancer’

    Regularly eating foods like bacon and sausages may raise the risk of breast cancer, according to researchers. A review of studies found women who ate high levels of processed meat had a 9 percent increased risk

    Evgen Pharma Plc

    Bad food habits could lead to cancer

    Enrich your diet with green tea, curcumin, pomegranate, and broccoli — rich in polyphenol — to keep cancers at bay, a nutritionist said, cautioning that unhealthy eating habits leads to cancer. “The key could be in

    Evgen Pharma Plc

    What are the early signs of MS?

    Multiple sclerosis is a progressive disease of the central nervous system. It occurs when the body’s immune system mistakenly attacks the healthy nerves of the brain and spinal cord. According to the National Multiple Sclerosis Society,

    Evgen Pharma Plc

    Evgen Pharma plc holding an Investor Symposium

    Evgen Pharma plc (LON: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, will be holding an Investor Symposium for investors and analysts today at the offices of Buchanan,

    Evgen Pharma Plc

    The Greenest of Greens

    We have all heard these words “Eat your greens” especially when it comes to green leafy vegetables that are rated as some of the best foods. Similarly green vegetables have also been called ‘superfoods’ as the

    Evgen Pharma Plc

    Living with MS and Remaining Positive

    Living with multiple sclerosis (MS) could be compared to having an annoying house guest that never leaves. At first you can tolerate them, but soon your nerves and resilience wear thin. You try to accept and

    Evgen Pharma Plc

    Evgen Pharma plc AGM Statement

    Evgen Pharma plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, will hold its Annual General Meeting later today in Manchester. At the AGM, the Company’s Chairman, Barry